Press Releases | Medtronic

Month Year

Email alerts

Dec 23, 2011

Medtronic CEO Omar Ishrak to Speak at JP Morgan Healthcare Conference

MINNEAPOLIS--(BUSINESS WIRE)--Dec. 23, 2011-- Medtronic, Inc. (NYSE: MDT), the world’s leading medical technology company, today announced it will participate in the 30th Annual JP Morgan...
Dec 20, 2011

Medtronic CEO Omar Ishrak to Speak at Goldman Sachs CEO Conference

MINNEAPOLIS--(BUSINESS WIRE)--Dec. 22, 2011-- Medtronic, Inc. (NYSE: MDT), the world’s leading medical technology company, today announced it will participate in the Goldman Sachs Healthcare...
Dec 12, 2011

Medtronic Reaches Settlement with United States Department of Justice

MINNEAPOLIS--(BUSINESS WIRE)--Dec. 12, 2011-- Medtronic, Inc. (NYSE: MDT) today announced that the Company has reached a settlement agreement with the United States Department of Justice (DOJ)...
Dec 10, 2011

Medtronic to Announce Financial Results for Its Second Quarter of the Fiscal Year 2012

MINNEAPOLIS, Nov 10, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) announced today it will report financial results for the second quarter of its fiscal year 2012 on Tuesday, November 22,...
Dec 9, 2011

Data Shows Medtronic AdaptiveStim™ with RestoreSensor™ Provides Pain Relief and Convenience

Neurostimulator with Innovative Motion Sensor Technology Was Recently Approved by the FDA for the Management of Chronic Pain

MINNEAPOLIS--(BUSINESS WIRE)--Dec. 9, 2011-- Clinical trial data presented at the 15th Annual Meeting of the North American Neuromodulation Society demonstrate the AdaptiveStim™ with...
Dec 8, 2011

Medtronic Announces Cash Dividend for Third Quarter of Fiscal Year 2012

MINNEAPOLIS, Dec 08, 2011 (BUSINESS WIRE) -- The board of directors of Medtronic, Inc. (NYSE:MDT) today approved a cash dividend of $0.2425 per share of the Company's common stock. The dividend is...
Dec 7, 2011

FDA Advisory Panel Recommends Expanded Indication for Medtronic Cardiac Resynchronization Therapy with Defibrillator (CRT-D) Devices

Medtronic CRT-D Devices Demonstrate Survival Benefits for Mildly Symptomatic Heart Failure Patients in Two Pivotal Clinical Trials

MINNEAPOLIS--(BUSINESS WIRE)--Dec. 7, 2011-- Medtronic, Inc. (NYSE: MDT) today announced that the U.S. Food and Drug Administration’s (FDA) Circulatory Systems Devices Advisory Panel determined...
Nov 21, 2011

Medtronic CFO Gary Ellis to Speak at Piper Jaffray Healthcare Conference

MINNEAPOLIS--(BUSINESS WIRE)--Nov. 21, 2011-- Medtronic, Inc. (NYSE: MDT), the world’s leading medical technology company, today announced it will participate in the Piper Jaffray Healthcare...
Nov 20, 2011

Medtronic Reports Second Quarter Earnings

Revenue of $4.1 Billion Grew 3% on a Constant Currency Basis, 6% as Reported

MINNEAPOLIS--(BUSINESS WIRE)--Nov. 22, 2011-- Medtronic, Inc. (NYSE:MDT) today announced financial results for its second quarter of fiscal year 2012, which ended October 28, 2011. The company...
Nov 20, 2011

Medtronic Receives FDA Approval for Next Generation Professional Continuous Glucose Monitoring

iPro®2 Simplifies Professional CGM for Improved Diabetes Therapy Management

MINNEAPOLIS--(BUSINESS WIRE)--Nov. 22, 2011-- Medtronic, Inc. (NYSE:MDT) today announced the Food and Drug Administration (FDA) approval of iPro®2, a next generation Professional continuous...

Show per page